1 December 2023 - Everest Medicines (HKEX 1952.HK), a China-based biopharmaceutical company, announced on Thursday positive topline data from a multi-centre Phase three clinical trial of Etrasimod in Asia intended for the treatment of moderate-to-sev...
1 December 2023 - Clarity Pharmaceuticals (ASX: CU6), an Australia-based, clinical stage radiopharmaceutical company, announced on Thursday that it has started its registrational Phase III 64Cu-SAR-bisPSMA diagnostic trial in prostate cancer, CLARIFY...
1 December 2023 - Soligenix, Inc. (Nasdaq: SNGX), a US-based, late-stage biopharmaceutical company, announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for the Investigational New Drug (IND) application ...
1 December 2023 - SciNeuro Pharmaceuticals, a China-based clinical stage biotech company developing treatments for neurodegenerative diseases, particularly Alzheimer's Disease (AD) and Parkinson's Disease (PD), announced on Thursday that it...
1 December 2023 - Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX), a Sweden-based commercial stage biopharma company, announced on Thursday that it has started a phase two clinical study to assess setanaxib in Alport syndrome, a g...